Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Cyclophosphamide × Clear all

NCT00470301 2021-02-16

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Phase 1/2 Completed

60 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00616122 2020-01-13

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Terminated

32 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00095862 2018-02-05

Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers

Phase 1/2 Terminated

Breast Neoplasms, Breast Neoplasms, Male

NCT00331552 2017-07-26

Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer

Phase 1/2 Completed

30 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00791037 2017-05-25

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Phase 1/2 Completed

23 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male